Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Cisplatin or Liposome Paclitaxel with RT for Elderly Cervical Cancer
NCT01594099Phase 2Unknown
- Sponsor
- Xi'an Jiaotong University
- Start
- Apr 2012
- Primary completion
- Oct 2013
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
01
Overview
Phase 2, randomised, open-label trial of cisplatin and liposomal paclitaxel in Cervical Cancer (CC) (3 arms), sponsored by Xi'an Jiaotong University. Primary endpoints: Objective Response Rate and Adverse Events. Status: unknown.
02
Drugs
cisplatinliposomal paclitaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT01594099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01594099.